23^rd International Conference on Pharmaceutical Biotechnology December 10-11, 2018 Rome, Italy

Henry M. Sobell completed his studies at Brooklyn Technical High School (1948-1952), Columbia College (1952-1956), and the University of Virginia School of Medicine (1956-1960). Instead of practicing clinical medicine, he then went to the Massachusetts Institute of Technology (MIT) to join Professor Alexander Rich in the Department of Biology (1960-1965), where, as a Helen Hay Whitney Postdoctoral Fellow, he learned the technique of single crystal X-ray analysis. He then joined the Chemistry Department at the University of Rochester, having been subsequently jointly appointed to both the Chemistry and Molecular Biophysics departments (the latter at the University of Rochester School of Medicine and Dentistry), becoming a full tenured Professor in both departments (1965-1993). He is now retired and living in the Adirondacks in New York, USA.

The centers of premeltons signal the beginning and ends of genes

Dr. Alain L Fymat is a physical-medical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine.

Dr. Fymat’s current research interests lie at the interface between science and medicine, particularly molecular/personal/precision medicine, nanomedicine, human genetics/epigenetics/ecogenetics, pharmacogenomics., and neurological diseases.

Isabel Desgagné-Penix has her expertise in plant biochemistry and specialized metabolism. Her research program aimed at understanding the molecular biology and biochemistry of isoquinoline alkaloid metabolism in Amaryllidaceae plants. Narcisses and snowdrops remains the only commercial source for the anti-cholinesterase galanthamine and several potential alkaloid pharmaceuticals. The recent availability of some Amaryllidaceae alkaloid biosynthetic genes creates metabolic engineering opportunities in plants and microorganisms. Her innovative and creative new ways to attempt production of valuable plant metabolites are of interest.

Systems biology and metabolic engineering of microalgae for the production of pharmaceutical Amaryllidaceae alkaloids.

Jorge Gonzalez Borroto is a Senior Nonclinical Toxicologist involved in Pharmacovigilance/Cosmetovigilance to support the efficacy, safety and well-use of medicines of the Company.

Drug Development, Drug Safety Evaluation, Pharmacovigilance and Risk Management during Post-marketing, Preclinical Toxicology.

After graduating with honours from the Physics Department at Moscow State University in 2000, Vladimir Baulin spent 3 years in the Commissariat à l’Energie Atomique, Grenoble, France, doing his PhD in theory of polymer physics and received a PhD in Physics in 2003. In 2004-2006 he was a postdoctoral researcher at the Institut Charles Sadron, Strasbourg, France. Since 2008 Vladimir Baulin leads a group of Soft mater theory at the University Rovira i Virgili, Tarragona, Spain (http://vbaulin.softmat.net). He is a Coordinator of EU funded Initial Training Network SNAL: Smart Nano-objects for Alteration of Lipid bilayers (http://itn-snal.net).

Theory and simulation of soft matter: polymers, surfactants, colloids, liquid crystals. Biophysics: self-organization of microtu

Dr. Wolfgang Fischer is Professor at the Institute of Biophotonics, School of Biomedical Science and Engineering, National Yang-Ming University, Taipei, Taiwan (www.ym.edu.tw/~wfischer/). He has obtained his PhD in Chemistry at Heidelberg University, Germany, working in the field of vibrational spectroscopy in 1991. After years in the US (Boston University, postdoctoral fellow working on bacteriorhodopsin using vibrational spectroscopy), Germany (TU-Dresden, Analytical Chemistry, working on ion channels as potential biosensors), UK (Oxford University as EU Marie Curie Research Fellow and later as Lecturer working on viral ion channels using bilayer recordings and molecular dynamics simulations) he moved to Taiwan. The field of research is on biophysical aspects describing dynamics and energetic of protein-protein interactions (PPIs) of membrane proteins. The focus is on the development of computational platform technologies to support drug discovery and design as well as materials sciences.

Targeting viral membrane proteins in silico